Literature DB >> 2945575

Influence of a variant angina on the results of percutaneous transluminal coronary angioplasty.

F Leisch, W Schützenberger, K Kerschner, W Herbinger.   

Abstract

Nineteen (86%) of 22 patients with variant angina and important coronary stenoses (greater than 60%) had successful percutaneous transluminal coronary angioplasty. The acute complications in two patients were not caused by coronary spasms but by dissection with disturbance of perfusion. One of these two patients required a coronary bypass graft; the other was treated conservatively. Myocardial infarction developed in both patients. Despite long term administration of nifedipine (30-80 mg daily), restenoses occurred within six months (on average after 10 weeks) in nine patients with symptoms and one without. In four patients the restenoses exceeded the degree of stenosis before angioplasty. Five patients were revascularised by surgical means. Vessels in three out of four patients were later successfully dilated. After a mean period of observation of 24 months (6-51 months) 18 of the 19 patients are symptom free and do not require medication. The results confirm that angioplasty is an effective method of treating patients with variant angina and important coronary stenoses. The problem of the high frequency of restenosis, however, remains unresolved.

Entities:  

Mesh:

Year:  1986        PMID: 2945575      PMCID: PMC1236868          DOI: 10.1136/hrt.56.4.341

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  25 in total

Review 1.  Coronary-artery spasm.

Authors:  L D Hillis; E Braunwald
Journal:  N Engl J Med       Date:  1978-09-28       Impact factor: 91.245

2.  Percutaneous transluminal coronary angioplasty.

Authors:  R I Levy; M B Mock; V I Willman; P L Frommer
Journal:  N Engl J Med       Date:  1979-07-12       Impact factor: 91.245

3.  Long-term prognosis of "variant" angina with medical treatment.

Authors:  S Severi; G Davies; A Maseri; P Marzullo; A L'Abbate
Journal:  Am J Cardiol       Date:  1980-08       Impact factor: 2.778

Review 4.  Contribution of dynamic vascular wall thickening to luminal narrowing during coronary arterial constriction.

Authors:  R N MacAlpin
Journal:  Circulation       Date:  1980-02       Impact factor: 29.690

5.  The variant form of angina: diagnostic and therapeutic implications.

Authors:  A Betriu; A Solignac; M G Bourassa
Journal:  Am Heart J       Date:  1974-03       Impact factor: 4.749

6.  "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients.

Authors:  A Maseri; S Severi; M D Nes; A L'Abbate; S Chierchia; M Marzilli; A M Ballestra; O Parodi; A Biagini; A Distante
Journal:  Am J Cardiol       Date:  1978-12       Impact factor: 2.778

7.  Variant angina pectoris: Clinical and anatomic spectrum and results of coronary bypass surgery.

Authors:  S J Shubrooks; J M Bete; A M Hutter; P C Block; M J Buckley; W M Daggett; E D Mundth
Journal:  Am J Cardiol       Date:  1975-08       Impact factor: 2.778

8.  Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty.

Authors:  A R Grüntzig; A Senning; W E Siegenthaler
Journal:  N Engl J Med       Date:  1979-07-12       Impact factor: 91.245

9.  Nifedipine therapy for coronary-artery spasm. Experience in 127 patients.

Authors:  E Antman; J Muller; S Goldberg; R MacAlpin; M Rubenfire; B Tabatznik; C S Liang; F Heupler; S Achuff; N Reichek; E Geltman; N Z Kerin; R K Neff; E Braunwald
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

10.  Spontaneous remission is a frequent outcome of variant angina.

Authors:  D D Waters; A Bouchard; P Théroux
Journal:  J Am Coll Cardiol       Date:  1983-08       Impact factor: 24.094

View more
  1 in total

Review 1.  A rare indication for stenting: persistent coronary artery spasm.

Authors:  H Kültürsay; L Can; S Payzin; C Türkoğlu; A Altintiğ; M Akin; A Akilli
Journal:  Heart Vessels       Date:  1996       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.